Literature DB >> 20122370

Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.

Nienke Jabben1, Baer Arts, Jim van Os, Lydia Krabbendam.   

Abstract

OBJECTIVE: Neurocognitive functioning may represent an indicator of genetic risk and poor outcome in both schizophrenia and bipolar disorder. In this study, shared and nonshared characteristics in the cognitive domain in both disorders were analyzed to determine to what degree neurocognitive functioning may represent a predictor of the familial vulnerability and poor functioning that schizophrenia spectrum disorders and bipolar disorder share.
METHOD: Neurocognition, psychopathology, and psychosocial functioning were assessed in samples of patients with a schizophrenia spectrum disorder (n = 345) and bipolar disorder (n = 76) meeting DSM-IV criteria, first-degree relatives of both patient groups (n = 331 and n = 37, respectively), and healthy controls (n = 260 and n = 61, respectively). Multiple regression models were used to investigate the effect of group status on neurocognition and to explore associations between cognition, symptoms, and psychosocial functioning in the 2 groups. The schizophrenia spectrum study sample was recruited between September 2004 and January 2008, and the bipolar study sample was recruited between June 2004 and July 2007.
RESULTS: Cognitive deficits were more severe and more generalized in patients with a schizophrenia spectrum disorder compared to patients with bipolar disorder; cognitive alterations were present in relatives of patients with schizophrenia spectrum disorders but not in relatives of bipolar patients. The association between neurocognitive dysfunction and psychosocial functioning was more generalized in schizophrenia spectrum disorders than in bipolar disorder; for both disorders, associations were only partly mediated by symptoms.
CONCLUSIONS: The evidence for cognitive dysfunction as a marker of familial vulnerability is stronger for schizophrenia than for bipolar disorder. Although the presence of multiple cognitive deficits is shared by the 2 groups, the severity of cognitive deficits and its consequences appear to partly differ between schizophrenia and bipolar disorder, which is in line with a model that implies the specific presence of a neurodevelopmental impairment in the former but not in the latter. 2010 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20122370     DOI: 10.4088/JCP.08m04837yel

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  19 in total

1.  Differences in resting-state functional magnetic resonance imaging functional network connectivity between schizophrenia and psychotic bipolar probands and their unaffected first-degree relatives.

Authors:  Shashwath A Meda; Adrienne Gill; Michael C Stevens; Raymond P Lorenzoni; David C Glahn; Vince D Calhoun; John A Sweeney; Carol A Tamminga; Matcheri S Keshavan; Gunvant Thaker; Godfrey D Pearlson
Journal:  Biol Psychiatry       Date:  2012-03-07       Impact factor: 13.382

2.  Normal birth weight variation is related to cortical morphology across the psychosis spectrum.

Authors:  Unn K Haukvik; Lars M Rimol; J Cooper Roddey; Cecilie B Hartberg; Elisabeth H Lange; Anja Vaskinn; Ingrid Melle; Ole A Andreassen; Anders Dale; Ingrid Agartz
Journal:  Schizophr Bull       Date:  2013-02-18       Impact factor: 9.306

Review 3.  A systems neuroscience perspective of schizophrenia and bipolar disorder.

Authors:  Sophia Frangou
Journal:  Schizophr Bull       Date:  2014-03-08       Impact factor: 9.306

4.  Cognition and community functioning in schizophrenia: The nature of the relationship.

Authors:  Susan S Kuo; Laura Almasy; Ruben C Gur; Konasale Prasad; David R Roalf; Raquel E Gur; Vishwajit L Nimgaonkar; Michael F Pogue-Geile
Journal:  J Abnorm Psychol       Date:  2018-02

5.  Meta-analysis of the association between cognitive abilities and everyday functioning in bipolar disorder.

Authors:  Colin A Depp; Brent T Mausbach; Alexandrea L Harmell; Gauri N Savla; Christopher R Bowie; Philip D Harvey; Thomas L Patterson
Journal:  Bipolar Disord       Date:  2012-05       Impact factor: 6.744

6.  Prospective predictors of mood episodes in bipolar disorder.

Authors:  Julia W Y Kam; Amanda R Bolbecker; Brian F O'Donnell; William P Hetrick; Colleen A Brenner
Journal:  J Affect Disord       Date:  2011-07-23       Impact factor: 4.839

7.  Resveratrol protects the brain against oxidative damage in a dopaminergic animal model of mania.

Authors:  Samira Menegas; Camila L Ferreira; José Henrique Cararo; Fernanda F Gava; Gustavo C Dal-Pont; Maria L Gomes; Jotele F Agostini; Patrícia Fernanda Schuck; Giselli Scaini; Monica L Andersen; João Quevedo; Samira S Valvassori
Journal:  Metab Brain Dis       Date:  2019-03-27       Impact factor: 3.584

8.  Verbal and visual-spatial memory impairment in youth at familial risk for schizophrenia or affective psychosis: a pilot study.

Authors:  Silvia Scala; Andrea Pousada; William S Stone; Heidi W Thermenos; Theo C Manschreck; Ming T Tsuang; Stephen V Faraone; Larry J Seidman
Journal:  Schizophr Res       Date:  2013-01-09       Impact factor: 4.939

9.  Reversal-learning deficits in childhood-onset bipolar disorder across the transition from childhood to young adulthood.

Authors:  Ezra Wegbreit; Grace K Cushman; Alexandra B Weissman; Erin Bojanek; Kerri L Kim; Ellen Leibenluft; Daniel P Dickstein
Journal:  J Affect Disord       Date:  2016-05-26       Impact factor: 4.839

Review 10.  Biomarkers of bipolar disorder: specific or shared with schizophrenia?

Authors:  Frank Bellivier; Pierre Alexis Geoffroy; Jan Scott; Franck Schurhoff; Marion Leboyer; Bruno Etain
Journal:  Front Biosci (Elite Ed)       Date:  2013-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.